By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Atara Biotherapeutics 

2659 Townsgate Road
Suite 236
Thousand Oaks  California  91361  U.S.A.
Phone: 805-309-0888 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
EBV-CTL Clinical Trial Data Presented By Atara Biotherapeutics' Collaborating Investigators At A Plenary Session At The AACR Annual Meeting 2015 4/20/2015 8:36:07 AM
Atara Biotherapeutics (ATRA)' Collaborating Investigators' Abstract On T-Cell Therapy For EBV Lymphoma To Be Presented At A Clinical Trials Plenary Session At The American Association for Cancer Research Annual Meeting 2015 Is Now Available 4/20/2015 7:43:51 AM
Atara Biotherapeutics (ATRA) To Present At The 2015 Jefferies and Co. Immuno-Oncology Summit 4/13/2015 8:01:21 AM
Atara Biotherapeutics (ATRA) To Present At The Needham Healthcare Conference 4/9/2015 6:15:58 AM
Atara Biotherapeutics (ATRA) Appoints Eric Dobmeier, Chief Operating Officer Of Seattle Genetics, Inc. (SGEN) To Its Board Of Directors 3/27/2015 6:16:34 AM
Atara Biotherapeutics (ATRA)' Collaborating Investigators To Present Clinical Data On T-Cell Therapy For EBV Lymphoma At A Clinical Trials Plenary Session At The American Association for Cancer Research Annual Meeting 2015 3/19/2015 7:59:59 AM
Atara Biotherapeutics (ATRA) Names David A. Carmel As Head Of Immunotherapy 3/3/2015 7:49:27 AM
Atara Biotherapeutics (ATRA) Release: FDA Grants Breakthrough Therapy Designation To Epstein-Barr Virus (EBV) Targeted T-Cells For Treatment Of EBV- Associated Lymphoproliferative Disease 3/2/2015 10:53:56 AM
Atara Biotherapeutics (ATRA) Announces Closing Of Underwritten Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 2/19/2015 7:49:53 AM
Atara Biotherapeutics (ATRA) Announces Pricing Of Its $65.5 Million Offering Of Common Stock 2/12/2015 7:28:19 AM
123
//-->